Dr. Elaine Schattner's notes on becoming educated as a patient
Dr. Elaine Schattner's notes on becoming educated as a patient
© Elaine Schattner, 2009, 2022 By : Template Sell.
This news reminds us an aspect of cancer treatment some of us would rather put out of our heads….all cancer patients should take careful notes on their planned treatments and ask their doctors about the long-term consequences of therapy.
My opinion is not quite formed on this new antibody. The FDA’s decision was based on results of one trial of 808 patients, half of whom didn’t get the experimental drug…
Fortunately the LATimes and People magazine got the story right. Their headlines, and text, emphasize the benign nature of Crow’s newly-diagnosed condition, a meningioma.
Last October, I met Suzanne at a conference. She seemed familiar; that was because I’d read about her life with metastatic breast cancer (MBC) a few months back…
The new agent is a hybrid of an old monoclonal antibody, Herceptin, that’s chemically attached to DM1, a traditional kind of chemotherapy. The preliminary results of this randomized trial are encouraging. …It’s hard to know how this promising, likely expensive, intravenous drug will fit in with others for patients with Her2+ breast cancer.
I want my doctors to be happy, up-to-date, and rested. What’s the point of so many busy, needed health professionals writing about their experiences or opinions, except if it’s for their own satisfaction?
From this plant comes an old chemotherapy drug, called Vincristine (Oncovin). When I practiced, I used this agent to treat people with lymphoma, some forms of leukemia, Kaposi’s sarcoma and…
When I was a resident I worked in a general medicine clinic. One afternoon each week, I’d get more dressed than usual and split off from my inpatient team around noon to go see patients in another building, outside of the hospital. Today, I’m reminded of a man I saw there and treated for two […]
Last week the National Breast Cancer Coalition (NBCC) held its annual summit. The meeting drew over 600 women to its opening rally in a Crystal City ballroom on Saturday, along with students who participated in sessions for Emerging Leaders, and a few men who joined in lectures and panels, and lobbied on Tuesday on Capitol […]
The 10 molecular BC categories bear prognostic (survival) information and, based on their distinct mutations and gene expression patterns, potential targets for novel drugs….I wonder if, in a few years, some breast cancers might be treated without surgery.
